Corticosteroids

Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Joan T Merrill, William R Shanahan, Morton Scheinberg, Kenneth C Kalunian, David Wofsy, Renee S Martin

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 883-889; DOI: 10.1136/annrheumdis-2018-213032
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
Kevin L Winthrop, John W Baddley

Annals of the Rheumatic Diseases May 2018, 77 (5) 631-633; DOI: 10.1136/annrheumdis-2017-212588
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, Yeong Wook Song, Suhnggwon Kim, Eun Bong Lee

Annals of the Rheumatic Diseases May 2018, 77 (5) 644-649; DOI: 10.1136/annrheumdis-2017-211796
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei, Yoshiya Tanaka, Tomonori Ishii, Shumpei Yokota, Akira Nomura, Seitaro Yoshida, Norihiro Nishimoto

Annals of the Rheumatic Diseases Mar 2018, 77 (3) 348-354; DOI: 10.1136/annrheumdis-2017-211878
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
Noortje Groot, Nienke de Graeff, Stephen D Marks, Paul Brogan, Tadej Avcin, Brigitte Bader-Meunier, Pavla Dolezalova, Brian M Feldman, Isabelle Kone-Paut, Pekka Lahdenne, Liza McCann, Seza Özen, Clarissa A Pilkington, Angelo Ravelli, Annet van Royen-Kerkhof, Yosef Uziel, Bas J Vastert, Nico M Wulffraat, Michael W Beresford, Sylvia Kamphuis

Annals of the Rheumatic Diseases Dec 2017, 76 (12) 1965-1973; DOI: 10.1136/annrheumdis-2017-211898
Glucocorticoids in rheumatoid arthritis: the picture is shaping up
Frank Buttgereit, Johannes W Bijlsma

Annals of the Rheumatic Diseases Nov 2017, 76 (11) 1785-1787; DOI: 10.1136/annrheumdis-2017-211187
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
Noortje Groot, Nienke de Graeff, Tadej Avcin, Brigitte Bader-Meunier, Paul Brogan, Pavla Dolezalova, Brian Feldman, Isabelle Kone-Paut, Pekka Lahdenne, Stephen D Marks, Liza McCann, Seza Ozen, Clarissa Pilkington, Angelo Ravelli, Annet van Royen-Kerkhof, Yosef Uziel, Bas Vastert, Nico Wulffraat, Sylvia Kamphuis, Michael W Beresford

Annals of the Rheumatic Diseases Nov 2017, 76 (11) 1788-1796; DOI: 10.1136/annrheumdis-2016-210960
Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort
Camille Roubille, Nathalie Rincheval, Maxime Dougados, René-Marc Flipo, Jean-Pierre Daurès, Bernard Combe

Annals of the Rheumatic Diseases Nov 2017, 76 (11) 1797-1802; DOI: 10.1136/annrheumdis-2016-210135
How to diagnose IgG4-related disease
Hisanori Umehara, Kazuichi Okazaki, Mitsuhiro Kawano, Tsuneyo Mimori, Tsutomu Chiba

Annals of the Rheumatic Diseases Nov 2017, 76 (11) e46; DOI: 10.1136/annrheumdis-2017-211330
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
Katerina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, Sofia Ramiro, Josef Smolen, Désirée van der Heijde, Maxime Dougados, Johannes Bijlsma, Gerd Burmester, Marieke Scholte, Ronald van Vollenhoven, Robert Landewé

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 1102-1107; DOI: 10.1136/annrheumdis-2016-210711

Main menu

Corticosteroids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Corticosteroids

Pages